Gemcitabine and pemetrexed: progress and new perspectives in treatment of thoracic cancersBELANI, Chandra; CARNEY, Desmond; LEE, Jin Soo et al.Lung cancer. 2005, Vol 50, issn 0169-5002, 28 p., SUP1Serial Issue

Incorporating novel agents with gemcitabine-based treatment of NSCLCTREAT, Joseph.Lung cancer. 2005, Vol 50, pp s8-s9, issn 0169-5002, SUP1Article

Standard therapy for the treatment of malignant pleural mesotheliomaVOGELZANG, Nicholas J.Lung cancer. 2005, Vol 50, pp s23-s24, issn 0169-5002, SUP1Article

Perspective on the development of new agents in thoracic cancersEINHORN, L.Lung cancer. 2005, Vol 50, pp s27-s28, issn 0169-5002, SUP1Article

Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabineCHOY, H; VOKES, E.Lung cancer. 2005, Vol 50, pp s10-s12, issn 0169-5002, SUP1Article

Seeking new options for the treatment of small-cell lung cancerSOCINSKI, M. A.Lung cancer. 2005, Vol 50, pp s25-s26, issn 0169-5002, SUP1Article

Using translational research to tailor the use of chemotherapy in the treatment of NSCLCBEPLER, Gerold.Lung cancer. 2005, Vol 50, pp s13-s14, issn 0169-5002, SUP1Article

A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabineNATALE, R.Lung cancer. 2005, Vol 50, pp s2-s4, issn 0169-5002, SUP1Article

Seeking improved outcome in the curative treatment of non-small-cell lung cancerVOKES, Everett.Lung cancer. 2005, Vol 50, pp s20-s22, issn 0169-5002, SUP1Article

The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancerCULLEN, M.Lung cancer. 2005, Vol 50, pp s5-s7, issn 0169-5002, SUP1Article

Advances in the treatment of second-line non-small-cell lung cancerHANNA, N.Lung cancer. 2005, Vol 50, pp s15-s17, issn 0169-5002, SUP1Article

Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancerSCAGLIOTTI, G. V.Lung cancer. 2005, Vol 50, pp s18-s19, issn 0169-5002, SUP1Article